Mohammad Farhad

ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial

John Wrangle, Vamsidhar Velcheti, Manish R. Patel et al. · The Lancet Oncology · 2018 · 426 citations

Medicine, Immunology, Oncology +12

Early evidence of anti-PD-1 activity in enzalutamide-resistant prostate cancer

Julie N. Graff, Joshi J. Alumkal, Charles G. Drake et al. · Oncotarget · 2016 · 360 citations · Full text

Medicine, Oncology, Pharmacology +8

Combination OX40 agonism/CTLA-4 blockade with HER2 vaccination reverses T-cell anergy and promotes survival in tumor-bearing mice

Stefanie N. Linch, Melissa J. Kasiewicz, Michael J. McNamara et al. · Proceedings of the National Academy of Sciences · 2016 · 76 citations · Full text

Life Sciences, Immunology, Oncology +17

Galectin-3 inhibition using novel inhibitor GR-MD-02 improves survival and immune function while reducing tumor vasculature

Stefanie N. Linch, Melissa J. Kasiewicz, Michael J. McNamara et al. · Journal for ImmunoTherapy of Cancer · 2015 · 11 citations · Full text

Medicine, Immunology, Pharmacology +6